{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CTMX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:51:43.434Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10001,"canonical_name":"CytomX Therapeutics, Inc.","cik":"0001501989","uei":null,"lei":null,"duns":null,"ticker":"CTMX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":25},"count":25,"timeline":[{"ts":"2026-10-16","kind":"sec.filing","form_type":"4/A","title":"4/A — CytomX Therapeutics, Inc. — 2026-10-16","url_slug":"/sec/cik-0001501989/4-a/0001610717-26-000442","accession_number":"0001610717-26-000442","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CytomX Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001501989/schedule-13g-a/0000919574-26-005484","accession_number":"0000919574-26-005484","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CytomX Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001501989/schedule-13g-a/0001907884-26-000014","accession_number":"0001907884-26-000014","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — CytomX Therapeutics, Inc. — 2026-08-07","url_slug":"/sec/cik-0001501989/schedule-13g/0000093751-26-000448","accession_number":"0000093751-26-000448","importance":55},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CytomX Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001501989/10-q/0001193125-26-337950","accession_number":"0001193125-26-337950","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — CytomX Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001501989/8-k/0001193125-26-338009","accession_number":"0001193125-26-338009","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"S-8","title":"S-8 — CytomX Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001501989/s-8/0001193125-26-338121","accession_number":"0001193125-26-338121","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"3","title":"3 — CytomX Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001501989/3/0001610717-26-000350","accession_number":"0001610717-26-000350","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — CytomX Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001501989/4/0001610717-26-000351","accession_number":"0001610717-26-000351","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — CytomX Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001501989/schedule-13g/0000070858-26-000395","accession_number":"0000070858-26-000395","importance":55},{"ts":"2026-08-03","kind":"sec.insider.a","reporter":"Carvajal Alejandra","title":"Chief Legal Officer","shares":100000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.filing","form_type":"3","title":"3 — CytomX Therapeutics, Inc. — 2026-07-30","url_slug":"/sec/cik-0001501989/3/0001610717-26-000344","accession_number":"0001610717-26-000344","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — CytomX Therapeutics, Inc. — 2026-07-30","url_slug":"/sec/cik-0001501989/4/0001610717-26-000345","accession_number":"0001610717-26-000345","importance":30},{"ts":"2026-07-27","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — CytomX Therapeutics, Inc. — 2026-07-27","url_slug":"/sec/cik-0001501989/schedule-13g/0002012383-26-002247","accession_number":"0002012383-26-002247","importance":55},{"ts":"2026-07-27","kind":"sec.filing","form_type":"8-K","title":"8-K — CytomX Therapeutics, Inc. — 2026-07-27","url_slug":"/sec/cik-0001501989/8-k/0001193125-26-316929","accession_number":"0001193125-26-316929","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — CytomX Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001501989/8-k/0001193125-26-277631","accession_number":"0001193125-26-277631","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — CytomX Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001501989/4/0001610717-26-000278","accession_number":"0001610717-26-000278","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — CytomX Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001501989/4/0001610717-26-000279","accession_number":"0001610717-26-000279","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — CytomX Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001501989/4/0001610717-26-000280","accession_number":"0001610717-26-000280","importance":30},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Ogden Christopher","title":"Chief Financial Officer","shares":1624,"price_per_share":3.05,"usd_value":4953,"security_title":"Common Stock","importance":35.0049532},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — CytomX Therapeutics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001501989/8-k/0001193125-26-255467","accession_number":"0001193125-26-255467","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CytomX Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001501989/schedule-13g-a/0001013594-26-000617","accession_number":"0001013594-26-000617","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CytomX Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001501989/schedule-13g-a/0001193125-26-227057","accession_number":"0001193125-26-227057","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CytomX Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001501989/schedule-13g-a/0001738048-26-000064","accession_number":"0001738048-26-000064","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CytomX Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001501989/schedule-13g-a/0001907884-26-000010","accession_number":"0001907884-26-000010","importance":30}]}